News from tarix pharmaceuticals A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Mar 05, 2013, 08:33 ET Tarix Pharmaceuticals' Peptide Technology Stimulates Revascularization Following Ischemia

Tarix Pharmaceuticals, a biopharmaceutical company focused on developing novel, peptide-based therapies to treat a range of critical medical...


Apr 26, 2011, 08:30 ET Tarix Pharmaceuticals Enrolls First Patient in Phase 1 Clinical Study of TXA127 in Adult Patients Following Double Cord Blood Stem Cell Transplant

Tarix Pharmaceuticals (www.tarixpharma.com) today announced enrollment of the first patient in a Phase 1 clinical study of TXA127, a pharmaceutical...


Feb 23, 2011, 04:51 ET Tarix Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Study of TXA127 Following Autologous Peripheral Blood Stem Cell Transplant

Tarix Pharmaceuticals (www.tarixpharma.com) today announced enrollment of the first patient in a Phase 2 clinical study of TXA127, a pharmaceutical...


Jun 28, 2010, 10:27 ET Tarix Pharmaceuticals' TXA127 Receives FDA Orphan Drug Designation for Stem Cell Engraftment

Tarix Pharmaceuticals (www.tarixpharma.com) today announced that it's drug, TXA127, has been granted Orphan Drug designation from the U.S. Food and...